UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Neuroimmune interactions: how the nervous and immune systems influence each other

Clinical and experimental immunology, 2019-09, Vol.197 (3), p.276-277

Taams, L. S.

2019

Volltextzugriff (PDF)

Inflammatory cytokines compromise programmed cell death‐1 (PD‐1)‐mediated T cell suppression in inflammatory arthritis through up‐regulation of soluble PD‐1

Clinical and experimental immunology, 2017-06, Vol.188 (3), p.455-466

2017

Volltextzugriff (PDF)

Mechanisms of checkpoint inhibition‐induced adverse events

Clinical and experimental immunology, 2020-05, Vol.200 (2), p.141-154

2020

Volltextzugriff (PDF)

Clinical & Experimental Immunology: Highlights of 2020

Clinical and experimental immunology, 2021-01, Vol.203 (1), p.1-2

2021

Volltextzugriff (PDF)

Immune checkpoint inhibition: from molecules to clinical application

Clinical and experimental immunology, 2020-05, Vol.200 (2), p.105-107

2020

Volltextzugriff (PDF)

Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis

Current rheumatology reports, 2015-08, Vol.17 (8), p.55-55, Article 55

2015

Volltextzugriff (PDF)

Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges

Clinical and experimental allergy, 2004-05, Vol.34 (5), p.761-769

2004

Volltextzugriff (PDF)

A randomized controlled trial protocol assessing the effectiveness, safety and cost‐effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)

British journal of dermatology (1951), 2018-12, Vol.179 (6), p.1297-1306

2018

Volltextzugriff (PDF)

Translational Mini-Review Series on Th17 Cells: CD4⁺ T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation

Clinical and experimental immunology, 2010-02, Vol.159 (2), p.137-147

2010

Volltextzugriff (PDF)

Comparative analysis of immune cell subsets in peripheral blood from patients with periodontal disease and healthy controls

Clinical and experimental immunology, 2018-12, Vol.194 (3), p.380-390

2018

Volltextzugriff (PDF)

Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis

Clinical and experimental immunology, 2013-11, Vol.174 (2), p.292-301

2013

Volltextzugriff (PDF)

The TREatment of severe Atopic eczema Trial (TREAT)

British journal of dermatology (1951), 2018-12, Vol.179 (6), p.e232-e232

2018

Volltextzugriff (PDF)

Peripheral generation and function of CD4+CD25+ regulatory T cells

Current topics in microbiology and immunology, 2005, Vol.293, p.115

2005

Volltextzugriff (PDF)

Psoriatic arthritis

British journal of hospital medicine (London, England : 2005), 2016-07, Vol.77 (7), p.C102

2016

Volltextzugriff (PDF)

Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis‐prone population

European journal of immunology, 2001-04, Vol.31 (4), p.1122-1131

2001

Volltextzugriff (PDF)

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

Human immunology, 2005-03, Vol.66 (3), p.222-230

2005

Volltextzugriff (PDF)

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of Fc epsilon RI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

Clinical and experimental allergy, 2011-10, Vol.41 (10), p.1400-1413

2011

Volltextzugriff (PDF)

32 CIRCULATING MONOCYTE ENDOTOXIN TOLERANCE IN ACUTE LIVER FAILURE: ROLE OF HEPATICALLY DERIVED IL-10

Journal of hepatology, 2011-03, Vol.54, p.S15-S15

2011

Volltextzugriff (PDF)

910 EXPANSION OF HEPATIC MACROPHAGES IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE: WHERE DO THEY COME FROM AND WHAT IS THEIR ROLE?

Journal of hepatology, 2011-03, Vol.54, p.S363-S363

2011

Volltextzugriff (PDF)

Anergic T cells as active regulators of the immune response

Human Immunology, 2000-07, Vol.61 (7), p.633-639

2000

Volltextzugriff (PDF)

‘Anergic’ T cells Modulate the T-cell Activating Capacity of Antigen-presenting Cells

Journal of autoimmunity, 2000-06, Vol.14 (4), p.335-341

2000

Volltextzugriff (PDF)

Type 1 IFN Maintains the Survival of Anergic CD4+ T Cells

The Journal of immunology (1950), 2000-10, Vol.165 (7), p.3782-3789

2000

Volltextzugriff (PDF)

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

Clinical and experimental allergy, 2011-10, Vol.41 (10), p.1400-1413

2011

Volltextzugriff (PDF)

Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19

PLoS genetics, 2022-03, Vol.18 (3), p.e1010042-e1010042

2022

Volltextzugriff (PDF)

Anergic T cells actively suppress T cell responses via the antigen‐presenting cell

European journal of immunology, 1998-09, Vol.28 (9), p.2902-2912

1998

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(101)
Buchkapitel
(24)
Bücher
(2)

Sprache

Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(62)
Humans
(59)
Immunology
(36)
Male
(30)
Female
(27)
Adult
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(20)
Middle Aged
(20)
Animals
(19)
Aged
(17)
Cardiovascular System & Cardiology
(17)
Cardiac & Cardiovascular Systems
(15)
Cd4-Positive T-Lymphocytes - Immunology
(15)
Calculus & Mathematical Analysis
(12)
Popular Science
(12)
Rats
(12)
Cytokines
(11)
T-Lymphocytes - Immunology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuroimmune interactions: how the nervous and immune systems influence each other

Inflammatory cytokines compromise programmed cell death‐1 (PD‐1)‐mediated T cell suppression in inflammatory arthritis through up‐regulation of soluble PD‐1

Mechanisms of checkpoint inhibition‐induced adverse events

Clinical & Experimental Immunology: Highlights of 2020

Immune checkpoint inhibition: from molecules to clinical application

Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis

Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges

A randomized controlled trial protocol assessing the effectiveness, safety and cost‐effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT)

Translational Mini-Review Series on Th17 Cells: CD4⁺ T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation

Comparative analysis of immune cell subsets in peripheral blood from patients with periodontal disease and healthy controls

Enhanced and persistent levels of interleukin (IL)‐17+CD4+ T cells and serum IL‐17 in patients with early inflammatory arthritis

The TREatment of severe Atopic eczema Trial (TREAT)

Peripheral generation and function of CD4+CD25+ regulatory T cells

Psoriatic arthritis

Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis‐prone population

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of Fc epsilon RI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

32 CIRCULATING MONOCYTE ENDOTOXIN TOLERANCE IN ACUTE LIVER FAILURE: ROLE OF HEPATICALLY DERIVED IL-10

910 EXPANSION OF HEPATIC MACROPHAGES IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE: WHERE DO THEY COME FROM AND WHAT IS THEIR ROLE?

Anergic T cells as active regulators of the immune response

‘Anergic’ T cells Modulate the T-cell Activating Capacity of Antigen-presenting Cells

Type 1 IFN Maintains the Survival of Anergic CD4+ T Cells

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity

Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19

Anergic T cells actively suppress T cell responses via the antigen‐presenting cell

Aktive Filter

Suchergebnisse filtern